Glaxosmithkline plc - ADR

GSK

$36.63

-4.75% (1 year change)

Avg closing price

Price range

Market Cap

$95 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

Revenue

$14.8 Billion

Total revenue in the last quarter.

Net Income

$1.52 Billion

Net income is all revenues minus all expenses including taxes and interest in the last quarter.

Earnings per Share

$3.11

Earnings per share is the amount of net income that is attributed to each single share outstanding.

Dividends per Share

$2.08 (5.5%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Price-Earnings Ratio

12.12x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

EBIT

$12 Million

Earnings before interest expenses and taxes in the last quarter.

Employees

0

The number of full time employees.

Revenue & Earnings

Balance Sheet

News

Outlook on the Digital Respiratory Devices Global Market to 2030 - Focus on Sensors, Smart Inhalers & Nebulizers, Application, Countries and Competitive Landscape

Outlook on the Digital Respiratory Devices Global Market to 2030 - Focus on Sensors, Smart Inhalers & Nebulizers, Application, Countries and Competitive Landscape

DUBLIN , April 19, 2021 /PRNewswire/ -- The "Global Digital Respiratory Devices Market 2021-2030: Focus on Sensors, Smart Inhalers & Nebulizers, Application, 9 Countries' Data, and Competitive Land...

Benzinga Benzinga, 3 days ago
GlaxoSmithKline shares jump at news of activist hedge fund interest

GlaxoSmithKline shares jump at news of activist hedge fund interest

UK pharmaceutical company has been under pressure to rebuild portfolio of new medicines

The Guardian The Guardian, 7 days ago
Americans might start getting a third booster shoot for Moderna vaccines this year (MRNA)

Americans might start getting a third booster shoot for Moderna vaccines this year (MRNA)

Summary List Placement COVID-19 vaccine shots aren't stopping anytime soon. Moderna announced Americans could start getting booster shots to protect against variant strains later this year. "It is ...

Business Insider Business Insider, 8 days ago